Just Released: "Hong Kong Pharmaceuticals & Healthcare Report Q4 2013"
BMI View: The attractiveness of Hong Kong's pharmaceutical market is dependent on its proximity to China as pharmaceutical firms are able to leverage on Hong Kong's relatively safe operating environment to expand into China. However, as China continues to advance in biotechnology and pharmaceutical, it will become a threat over the long term. Equally relevant is its domestic demographic, where is ageing and affluent population will continue to sustain demands for pharmaceuticals and healthcare services. Similar to Singapore, Hong Kong's...
View full press release